Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing the Efficacy of ICIs With and Without MWA in Advanced Hepatocellular Carcinoma in Real-World Clinical Practice

NCT06581497 is registered in ClinicalTrials.gov with The First People's Hospital of Neijiang as lead sponsor.

NCT NCT06581497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06581497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing the Efficacy of ICIs With and Without MWA in Advanced Hepatocellular Carcinoma in Real-World Clinical Practice
Lead sponsor
The First People's Hospital of Neijiang
Phase
Observational
Overall status
Completed
Start date
January 1, 2022
Completion date
January 1, 2026
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hcc, therapy adverse effect